According to Fact.MR, the sales of plasma fractionation is expected to register a CAGR of more than 7% along with the market size being valued at US$ 38 Bn at the end of the 2021-2031 forecast period. Rising prevalence of infectious and chronic diseases is majorly spurring expansion of the market.
As per historical trends, between 2016 and 2020, demand for plasma fractionation surged at a CAGR of 5%, closing in at a valuation of US$ 19 Bn. The impact of COVID-19 has been tremendously huge on the plasma fractionation market. Increase in respiratory problems and blood disorders has led to patients opting for plasma fractionation. Technological advancements in the plasma fractionation sector has further propelled the growth of plasma fractionation.
Prominent manufacturers are expected to capitalize on the ever-growing prospects for treating neurological disorders. Statistics suggest that these disorders have affected 450 million globally. Thus, the neurology segment for plasma fractionation is expected to witness robust growth by registering a CAGR of 7.2%
For detailed insights on enhancing your product footprint, request a sample here- https://www.factmr.com/connectus/sample?flag=S&rep_id=4806
A detailed assessment of the plasma fractionation market value chain analysis, business execution, and supply chain analysis across the regional markets has been covered in the report. A list of prominent companies operating in the plasma fractionation market along with their product portfolio enhances the reliability of this comprehensive research study.
“Burgeoning technological innovations, combined with widespread usage of immunoglobulins for treating various neurological and autoimmune diseases shall broaden growth prospects. A positive growth trajectory is predicted for the plasma fractionation market during the forecast period,” infers a Fact.MR analyst.
Prominent manufacturers with established market presence in global Plasma fractionation market are
- GRIFOLS
- Sanquin
- CSL Behring Limited
- Shire Plc.
- Biotest AG
- Baxter International
COVID-19 Analysis on the Global Plasma Fractionation Market
A recent market research report on the Plasma Fractionation market published by Fact.MR is an in-depth assessment of the current landscape of the market. Further, the report elaborates on the impact of the COVID-19 on the Plasma Fractionation market and provides a thorough understanding of the growth potential of each market segment over the forecast period (2020 to 2026).
Need more information about Report Methodology? Click here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=4806
Plasma Fractionation Market: Report Summary
The study offers a comprehensive analysis on diverse features including production capacities, demand, product developments, revenue generation and sales in the plasma fractionation market across the globe.
A comprehensive estimate on the plasma fractionation market has been provided through an optimistic as well as a conservative scenario, taking into account the sales of plasma fractionation market during the forecast period.
Plasma Fractionation Market Segmentation
Fact.MR has studied the plasma fractionation market with detailed segmentation on the basis of product, application, end-user and region.
For comprehensive insights on this market adoption, ask an analyst here- https://www.factmr.com/connectus/sample?flag=AE&rep_id=4806
| Product |
Application |
End-user |
Region |
Immunoglobulins:
- Intravenous Immunoglobulins
- Subcutaneous Immunoglobulins
|
Neurology |
Hospitals & Clinics |
North America |
Coagulation Factor Concentrates:
- Factor VIII
- Factor IX
- Factor XIII
- Prothrombin Complex Concentrate
- Von Willebrand Factor (VWF)
- Fibrinogen Concentrates
|
Immunology |
Clinical Research Laboratories |
Europe |
| Albumin |
Hematology |
Academic Institutions |
Asia Pacific |
| Protease Inhibitors |
Critical Care |
|
Latin America |
| Other Plasma Products |
Pulmonary |
|
Middle East & Africa |
|
Other Applications |
|
|
“This taxonomy prepared is confidential and intended exclusively for the individual or entity with whom it is being shared. Reading, disseminating, distributing, or copying this to any party other than addressee(s) is unauthorized and prohibited.”
For in-depth competitive analysis, buy now- https://www.factmr.com/checkout/4806
Plasma Fractionation Market: Analysis on Market Size Evaluation
The plasma fractionation market has been analyzed for each market segment, in terms of value (US$ Mn).
Market estimates at global and regional levels for Plasma fractionation market is available in terms of “US$ Mn” for value. A Y-o-Y growth contrast on prominent plasma fractionation market segments, along with market attractiveness evaluation has been incorporated in the report.
Plasma Fractionation Market: Inspected Assessment on Regional Segments
Key sections have been elaborated in the plasma fractionation report, which have helped deliver projection on the regional markets. These chapters include the regional macros (economic and business environment outlook), which are expected to have a momentous influence on the growth of the plasma fractionation market during the forecast period.
For More Insights: https://www.prnewswire.com/news-releases/ear-nose-throat-ent-medical-devices-manufacturers-target-applications-in-cataract–glaucoma-treatment-factmr-301262063.html
Country-specific valuation on demand for plasma fractionation has been offered for each regional market, along with the market scope estimate and forecast, price index, and impact analysis of dynamics of prominence in regions and countries. For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.
Detailed breakup in terms of value for emerging countries has also been included in the report.
Plasma Fractionation Market: In-Depth Analysis on Competitive Landscape
The report sheds light on the leading manufacturers of plasma fractionation products along with their detailed profiles. Essential and up-to-date data information related to the market performers, who are principally engaged in the production of plasma fractionation products, has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits the report readers to take preemptive steps in advancing their businesses.
Company profiles have been included in the report, such as product portfolio, key strategies along with an all-inclusive SWOT analysis on each player. Company presence is mapped and presented through the matrix for all the prominent players thus providing the readers with actionable insights, which helps in thoughtfully presenting market status, and predicting the competition level in the plasma fractionation market. Prominent manufacturers with established market presence in global Plasma fractionation market are GRIFOLS, Sanquin, CSL Behring Limited, Shire Plc., Biotest AG, Baxter International, etc.
About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
